Poirrier JE, Meyers JL, Nagar SP, Patterson BJ, Glasser LI, Jabbour SA. Herpes zoster incidence and burden in adults with type 2 diabetes in the U.S.: a retrospective database analysis. Diabetes Care. 2022 Nov 1;45(11):2585-93. doi: 10.2337/dc21-2053
Mody R, Meyers J, Yu M, Davis K, Levine JA. Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States. Curr Med Res Opin. 2022 Nov;38(11):1785-95. doi: 10.1080/03007995.2022.2085962.
Wilburn J, McKenna SP, Twiss J. Further developments of the rheumatoid arthritis quality of life scale (RAQoL). Poster presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, Spain. [abstract] Value Health. 2009 Oct; 12(7):A447-8. doi: 10.1016/S1098-3015(10)75215-3
Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. 2009 Oct 1;36(10):2318-29.
Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis. 2009 Jul;68(7):1177-83. doi: 10.1136/ard.2008.094904
Lunt M, Solomon D, Rothman KJ, Glynn R, Hyrich K, Symmons DP, Stürmer T. Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. Am J Epidemiol. 2009 Apr;169(7):909-17.